Literature DB >> 7961539

The natural history and heterogeneity of depressive disorders: implications for rational antidepressant therapy.

M B Keller1, D L Hanks.   

Abstract

Depression is a chronic, recurrent illness that affects approximately 8% of the U.S. population. There are several types of depressive disorders including major depression, unipolar depression, bipolar depression, double depression, and dysthymia. For those afflicted, each type of depressive disorder can cause a loss of productivity, job status, and income and can result in poor health and suicide. Depression also has a high rate of comorbidity with other disorders, especially anxiety disorders and alcoholism; yet, depression is still undertreated and underrecognized by most physicians. This is particularly unfortunate because there are many antidepressant medications currently available that are effective in treating this insidious illness. To continue to combat this dangerous illness, more clinical trials are needed to help us maximize the benefits and minimize the risks associated with current antidepressant medications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961539

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Antidepressant utilization in Canada.

Authors:  Cynthia A Beck; Scott B Patten; Jeanne V A Williams; Jian Li Wang; Shawn R Currie; Colleen J Maxwell; Nady El-Guebaly
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10       Impact factor: 4.328

2.  Current Perspectives on the Diagnosis and Treatment of Double Depression.

Authors:  D J Hellerstein; S A Little
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

3.  From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples.

Authors:  R Bruce Lydiard; Philip Perera; Evan Batzar; Cathryn M. Clary
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-10

4.  Escitalopram: A New SSRI for the Treatment of Depression in Primary Care.

Authors:  Larry Culpepper
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.